SwePub
Sök i LIBRIS databas

  Extended search

id:"swepub:oai:DiVA.org:umu-11787"
 

Search: id:"swepub:oai:DiVA.org:umu-11787" > A small-molecule in...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

A small-molecule inhibitor of type III secretion inhibits different stages of the infectious cycle of Chlamydia trachomatis

Muschiol, Sandra (author)
Karolinska Institutet
Bailey, Leslie (author)
Umeå universitet,Institutionen för molekylärbiologi (Medicinska fakulteten)
Gylfe, Åsa (author)
show more...
Sundin, Charlotta (author)
Umeå universitet,Institutionen för molekylärbiologi (Teknisk-naturvetenskaplig fakultet)
Hultenby, Kjell (author)
Karolinska Institutet
Bergström, Sven (author)
Umeå universitet,Institutionen för molekylärbiologi (Medicinska fakulteten)
Elofsson, Mikael (author)
Umeå universitet,Kemiska institutionen
Wolf-Watz, Hans (author)
Umeå universitet,Institutionen för molekylärbiologi (Teknisk-naturvetenskaplig fakultet)
Normark, Staffan (author)
Karolinska Institutet
Henriques-Normark, Birgitta (author)
Karolinska Institutet
show less...
 (creator_code:org_t)
2006-09-26
2006
English.
In: National Academy of Sciences, USA. - Washington : Proceedings of the National Academy of Sciences. ; , s. 14566-71
  • Conference paper (other academic/artistic)
Abstract Subject headings
Close  
  • The intracellular pathogen Chlamydia trachomatis possesses a type III secretion (TTS) system believed to deliver a series of effector proteins into the inclusion membrane (Inc-proteins) as well as into the host cytosol with perceived consequences for the pathogenicity of this common venereal pathogen. Recently, small molecules were shown to block the TTS system of Yersinia pseudotuberculosis. Here, we show that one of these compounds, INP0400, inhibits intracellular replication and infectivity of C. trachomatis at micromolar concentrations resulting in small inclusion bodies frequently containing only one or a few reticulate bodies (RBs). INP0400, at high concentration, given at the time of infection, partially blocked entry of elementary bodies into host cells. Early treatment inhibited the localization of the mammalian protein 14-3-3beta to the inclusions, indicative of absence of the early induced TTS effector IncG from the inclusion membrane. Treatment with INP0400 during chlamydial mid-cycle prevented secretion of the TTS effector IncA and homotypic vesicular fusions mediated by this protein. INP0400 given during the late phase resulted in the detachment of RBs from the inclusion membrane concomitant with an inhibition of RB to elementary body conversion causing a marked decrease in infectivity.

Keyword

14-3-3 Proteins/metabolism
Anti-Bacterial Agents/chemistry/*pharmacology
Bacterial Proteins/*antagonists & inhibitors/metabolism
Cell Differentiation
Cell Membrane/metabolism
Chlamydia Infections/*drug therapy
Chlamydia trachomatis/cytology/*drug effects/*physiology/ultrastructure
Dose-Response Relationship; Drug
Inclusion Bodies/ultrastructure
Membrane Fusion
Phosphoproteins/metabolism
Protein Binding
Protein Transport

Publication and Content Type

vet (subject category)
kon (subject category)

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view